Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2026-03-05 @ 2:07 PM
Study NCT ID:
NCT00548405
Status:
COMPLETED
Last Update Posted:
2017-04-17
First Post:
2007-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
Sponsor:
Organization: